New N-phenylsulfonyl-3-amidino-phenylalanine piperidide derivatives useful as antitumor agents
DE102006062203A1
Substituted 5H-pyrimido [5,4-b] indoles as inducers of apoptosis in B-CLL cells
DE102006050672A1
New glycylglycine derivatives with a benzylsulfonylamido group and an amidino-organylamido group at the opposite chain ends, used in drugs for reducing loss of blood, e.g. in operations
WO2006074919A2
3-AMINO-6-ARYL(OR 6-HETEROARYL)-THIENO[2,3-B]PYRIDIN-2-CARBOXAMIDES, PHARMACEUTICAL PREPARATIONS CONTAINING THE SAME AND THEIR USE AS TNFα INHIBITORS
WO2006010568A2
Substituted pyrido[3',2':4,5]thieno[3,2-d]pyrimidine-2,4(1 h,3h)-diones and -4(3h)-ones, pyrido[3',2':4,5]furo[3,2-d]pyrimidine-2,4(1 h,3h)-diones and -4(3h)-ones, and use thereof as inhibitors of tnf-alpha release
DE102005013622A1
New tricyclic thiophene or furan derivatives useful as tumor necrosis factor alpha inhibitors, e.g. for treating asthma, chronic obstructive pulmonary disease, rheumatoid arthritis, osteoarthritis, multiple sclerosis
DE102005013621A1
Substituted 2-aryl (hetaryl) -5-aminothieno [2,3-d] pyrimidine-6-carboxylic acid amides, process for their preparation and use as pharmaceuticals
EP1642965A1
Use of differentiated fibroblasts or of a primary fibtroblast culture for the transdifferentiation of adipocytes, osteoblasts and chondrocytes
EP1623987A1
Fused pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and pyrido[3',2':4,5]furo[3,2-d]pyrimidines
EP1619197A1
Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido[3',2':4,5]furo[3,2-d]-pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release
EP1619196A1
Substituted Pyrido[3',2':4,5]thieno[3,2-d]pyrimidines and Pyrido[3',2':4,5]furo[3,2-d]-pyrimidines for use as inhibitors of PDA-4 and/or TNF-alpha release
